Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994, 90:195–203.
Houben AJ, van der-Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005, 19:411–419.
Steiner J, Guglin M. BNP or NTproBNP? A clinician’s perspective. Int J Cardiol. 2008, 129:5–14.
Clerico A, Carlo Zucchelli G, Pilo A, Passino C, Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med. 2006, 44:366–378.
Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN. (on behalf of the Val-HeFT Investigators) Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a larger population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure data. Clin Chem. 2006, 52:1528–1538.
Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007, 50:2357–68.
Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006, 34:995–1000.
Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F. The influence of age, sex and other variables on the plasma level of N- terminal pro brain natriuretic peptide in a large sample of the general population. Heart. 2003, 89:745–751.
Rossi A, Enriquez-Sarano M, Burneet JC, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation. J Am Coll Cardiol. 2000, 35:1256–1262.
Avidan MS, Meehan N, Ponte J, El-Gamel A, Sherwood RA. Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta. 2001, 303:127–132.
Morimoto K, Mori T, Ishiguro S, Matsuda N, Hara Y, Kuroda H. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today. 1998, 28:23–29.
Nozohoor S, Nilsson J, Lührs C, Roijer A, Algotsson L, Sjögren J. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement. J Cardiothorac Vasc Anesth. 2009, 23:161–165.
Attaran S, Sherwood R, Desai J, Langworthy R, Mhandu P, John L, El-Gamel A. Brain natriuretic peptide a predictive marker in cardiac surgery. Interact CardioVasc Thorac Surg. 2009, 9:662–666.
Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004, 43:1873–1879.
Sodeck G, Domanovits H, Schillinger M, Janata K, Thalmann M, Ehrlich MP, Endler G, Laggner A. Pre-operative N-Terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J Am Coll Cardiol. 2008, 51:1092–1097.
Crescenzi G, Landoni G, Bignami E, Belloni I, Biselli C, Rosica C, Guarracino F, Marino G, Zanqrillo A. N-terminal B- natriuretic peptide after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2009, 23:147–150.
